Analystreport

Avenue Therapeutics Inc (NASDAQ: ATXI) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.

Avenue Therapeutics, Inc.  (ATXI) 
Last avenue therapeutics, inc. earnings: 8/14 07:30 am Check Earnings Report